Clinical Trial Update: Identification of Novel Markers of Human Lung Disease

View source ↗

Summary

The Ohio State University-sponsored trial 'Identification of Novel Markers of Human Lung Disease' evaluating interstitial lung diseases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Snippet

Sponsor: Ohio State University | Conditions: Lung Diseases, Interstitial | Status: WITHDRAWN